Form D · Biotechnology
ALDAGEN INC
Durham, NC · CIK 0001128188
Offering snapshot reported Jan 13, 2012 · SEC filing
- Reported sold
- $585K Offering amount: $645K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$525,004 → $585,004
- Reported investors11 → 13
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2012 | Amendment | $585,004 | $60,000vs Oct 3, 2011 | 13 | SEC filing |
| Oct 3, 2011 | Initial | $525,004 | No comparison | 11 | SEC filing |
| Jun 23, 2011 | Initial | $1,080,377 | No comparison | 11 | SEC filing |
| Nov 24, 2009 | Amendment | $7,287,902 | $0vs Oct 27, 2009 | 10 | SEC filing |
| Oct 27, 2009 | Initial | $7,287,902 | No comparison | 10 | SEC filing |
| Apr 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 3, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 13, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-166672
Source: Form D, filed Jan 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| W. Thomas Amick | Director, Executive |
| Andrew E. Balber | Executive |
| William Brooke | Director |
| David Carberry | Executive |
| B. Jefferson Clark | Director |
| B Jefferson Clark | Director |
| Dennis Dougherty | Director |
| William Evans | Director |
| Edward Field | Executive |
| James Hinson | Executive |
| Jim Hinson | Executive |
| Lyle A Hohkne | Director, Executive |
| Lyle A. Hohnke | Director, Executive |
| Richard Kent | Director |
| Joel Kimbrough | Director |
| Garheng Kong | Director |
| Martin Murphy | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2810 Meridian Parkway Suite 148
Durham, NC, 27713
Durham, NC, 27713